Carter's Inc. (CRI)
CRI (NYSE:Consumer Non-Durables)
$70.20
+0.31
+0.44%
Today's Range: 69.16 - 70.36 |
CRI Avg Daily Volume: 897,000
| Last Update: 05/24/13 - 4:01 PM EDT |
| Volume: 651,792 |
| YTD Performance: 26.15%
|
| Open: $69.22 |
| Previous Close: $69.89 |
| 52 Week Range: $48.67 -
$71.90 |
| Oustanding Shares: 59,248,611 |
| Market Cap: 4,140,885,423 |
6-Month Chart
TheStreet Ratings Grade for CRI
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
2 |
2 |
2 |
2 |
| Moderate Buy |
0 |
0 |
0 |
0 |
| Hold |
3 |
2 |
3 |
4 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
0 |
0 |
0 |
0 |
| Mean Rec. |
2.20 |
2.00 |
2.20 |
2.33 |
| Latest Dividend: |
0.16 |
| Latest Dividend Yield: |
0.92% |
| Dividend Ex-Date: |
05/29/13 |
| Price Earnings Ratio: |
24.61 |
|
| Price Earnings Comparisons: |
| CRI |
Sector Avg. |
S&P 500 |
| 24.61 |
24.60 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
20.18%
|
32.53%
|
134.00%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
12.90 |
0.50 |
0.14 |
| Net Income |
41.30 |
0.39 |
0.12 |
| EPS |
38.70 |
0.34 |
0.10 |
| Earnings for CRI: |
| EBITDA |
0.27B |
| Revenue |
2.38B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.43 |
$1.13 |
$3.38 |
$4.04 |
| Number of Analysts |
3 |
2 |
4 |
3 |
| High Estimate |
$0.45 |
$1.20 |
$3.51 |
$4.16 |
| Low Estimate |
$0.42 |
$1.06 |
$3.32 |
$3.85 |
| Prior Year |
$0.37 |
$1.02 |
$2.85 |
$3.38 |
| Growth Rate (Year over Year) |
16.22% |
10.78% |
18.77% |
19.25% |
Dec 18, 2012 | 7:38 AM EST
Shares of CRI now seen reaching $64, Citigroup said. Estimates also increased as supply chain restructuring an underestimated catalyst ...
Jul 26, 2012 | 7:53 AM EDT
CRI was upgraded to Buy, Sterne Agee said. $60 price target. New initiatives should drive growth over the next several quarters.
...
May 25, 2012 | 7:09 AM EDT
CRI was upgraded to Buy from Neutral, Citigroup said. $62 price target. EBIT margin trumps competitors and still expanding....
May 15, 2012 | 7:13 AM EDT
CRI was initiated with a Market Perform rating, FBR Capital Markets said. Valuation call, based on a $54 price target.
| Dec 07, 2011 | 6:10 AM EST
Add these 'B' or 'C' letter stocks from the 'alphabet soup' watch list on a retrace.
Dec 06, 2011 | 7:32 AM EST
CRI was upgraded from Neutral to Buy, Goldman Sachs said. Company is raising prices in its wholesale business. $46 price target.
